Literature DB >> 16244853

Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database.

D J Anderson1, L Olaison, J R McDonald, J M Miro, B Hoen, C Selton-Suty, T Doco-Lecompte, E Abrutyn, G Habib, S Eykyn, P A Pappas, V G Fowler, D J Sexton, M Almela, G R Corey, C H Cabell.   

Abstract

Enterococcal prosthetic valve infective endocarditis (PVE) is an incompletely understood disease. In the present study, patients with enterococcal PVE were compared to patients with enterococcal native valve endocarditis (NVE) and other types of PVE to determine differences in basic clinical characteristics and outcomes using a large multicenter, international database of patients with definite endocarditis. Forty-five of 159 (29%) cases of definite enterococcal endocarditis were PVE. Patients with enterococcal PVE were demographically similar to patients with enterococcal NVE but had more intracardiac abscesses (20% vs. 6%; p=0.009), fewer valve vegetations (51% vs. 79%; p<0.001), and fewer cases of new valvular regurgitation (12% vs. 45%; p=0.01). Patients with either enterococcal PVE or NVE were elderly (median age, 73 vs. 69; p=0.06). Rates of in-hospital mortality, surgical intervention, heart failure, peripheral embolization, and stroke were similar in both groups. Patients with enterococcal PVE were also demographically similar to patients with other types of PVE, but mortality may be lower (14% vs. 26%; p=0.08). Notably, 93% of patients with enterococcal PVE came from European centers, as compared with only 79% of patients with enterococcal NVE (p=0.03). Thus, patients with enterococcal PVE have higher rates of myocardial abscess formation and lower rates of new regurgitation compared to patients with enterococcal NVE, but there are no differences between the groups with regard to surgical or mortality rates. In contrast, though patients with enterococcal PVE and patients with other types of PVE share similar characteristics, mortality is higher in the latter group. Importantly, the prevalence of enterococcal PVE was higher in the European centers in this study.

Entities:  

Mesh:

Year:  2005        PMID: 16244853     DOI: 10.1007/s10096-005-0007-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

1.  Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-72.

Authors:  L L Pelletier; R G Petersdorf
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

Review 2.  Infective endocarditis in the antibiotic era.

Authors:  P I Lerner; L Weinstein
Journal:  N Engl J Med       Date:  1966-01-27       Impact factor: 91.245

3.  Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used?

Authors:  Lars Olaison; Kimmo Schadewitz
Journal:  Clin Infect Dis       Date:  2001-12-07       Impact factor: 9.079

4.  Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis.

Authors:  B Hoen; C Chirouze; C H Cabell; C Selton-Suty; F Duchêne; L Olaison; J M Miro; G Habib; E Abrutyn; S Eykyn; Y Bernard; F Marco; G R Corey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

5.  Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.

Authors:  W R Wilson; C J Wilkowske; A J Wright; M A Sande; J E Geraci
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

6.  Enterococcal bacteremia in two large community teaching hospitals.

Authors:  D A Malone; R A Wagner; J P Myers; C Watanakunakorn
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

7.  Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study.

Authors:  D J Anderson; D R Murdoch; D J Sexton; L B Reller; J E Stout; C H Cabell; G R Corey
Journal:  Infection       Date:  2004-04       Impact factor: 3.553

8.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.

Authors:  D T Durack; A S Lukes; D K Bright
Journal:  Am J Med       Date:  1994-03       Impact factor: 4.965

9.  Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database.

Authors:  C Chirouze; C H Cabell; V G Fowler; N Khayat; L Olaison; J M Miro; G Habib; E Abrutyn; S Eykyn; G R Corey; C Selton-Suty; B Hoen
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

10.  Enterococcal bacteremia without endocarditis.

Authors:  D M Shlaes; J Levy; E Wolinsky
Journal:  Arch Intern Med       Date:  1981-04
View more
  8 in total

1.  Cardiovascular implantable device infections.

Authors:  George M Viola; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

Review 2.  Infective endocarditis.

Authors:  Yok-Ai Que; Philippe Moreillon
Journal:  Nat Rev Cardiol       Date:  2011-04-12       Impact factor: 32.419

3.  Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines.

Authors:  Sara K Pasquali; Xia He; Zeinab Mohamad; Brian W McCrindle; Jane W Newburger; Jennifer S Li; Samir S Shah
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

Review 4.  Acute infective endocarditis.

Authors:  Jay R McDonald
Journal:  Infect Dis Clin North Am       Date:  2009-09       Impact factor: 5.982

Review 5.  Fatal Enterococcus durans aortic valve endocarditis: a case report and review of the literature.

Authors:  Rajakrishnan Vijayakrishnan; Alwyn Rapose
Journal:  BMJ Case Rep       Date:  2012-06-08

6.  Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.

Authors:  Philippe Moreillon; Walter R Wilson; Roland Leclercq; José M Entenza
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

7.  Are histopathological findings of diagnostic value in native valve endocarditis?

Authors:  F Zauner; T Glück; B Salzberger; B Ehrenstein; G Beutel; F Robl; F Hanses; D Birnbaum; H J Linde; F Audebert
Journal:  Infection       Date:  2013-02-02       Impact factor: 3.553

8. 

Authors:  H Staedt; D Heimes; P W Kämmerer
Journal:  Wissen Kompakt (Heidelb)       Date:  2021-08-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.